Novel Cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: A suitability study

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 77, Issue 1, 2011, Pages 56-65

  Mondon, K ^a   Zeisser Laboube, M ^a   Gurny, R ^a   Moller M ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Biocompatibility; CAM model; Cyclosporin A; Drug delivery; Polymeric micelles; Substituted polylactides

Indexed keywords

CYCLOSPORIN A; MACROGOL; POLYLACTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CHORIOALLANTOIS; CLINICAL EVALUATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; EMBRYO; HEMOLYSIS; HUMAN; HUMAN CELL; MICELLE; NONHUMAN; RECOMMENDED DRUG DOSE; SHELF LIFE;

ANIMALS; CELL LINE; CELL SURVIVAL; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEASIBILITY STUDIES; HEMOLYSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICELLES; NANOTECHNOLOGY; PHYSICOCHEMICAL PHENOMENA; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; TOXICITY TESTS;

EID: 78650715703     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.09.012     Document Type: Article

References (38)

1. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Deliv. Rev. 60 2008 1615 1626
2. D.K. Chatterjee, L.S. Fong, and Y. Zhang Nanoparticles in photodynamic therapy: an emerging paradigm Adv. Drug Deliv. Rev. 60 2008 1627 1637
3. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
4. G.S. Kwon Polymeric micelles for delivery of poorly water-soluble compounds Crit. Rev. Ther. Drug Carrier Syst. 20 2003 357 403
5. S.R. Croy, and G.S. Kwon Polymeric micelles for drug delivery Curr. Pharm. Des. 12 2006 4669 4684
6. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16
7. H. Maeda, G.Y. Bharate, and J. Daruwalla Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect Eur. J. Pharm. Biopharm. 71 2009 409 419
8. M.P. Desai, V. Labhasetwar, E. Walter, R.J. Levy, and G.L. Amidon The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent Pharm. Res. 14 1997 1568 1573
9. S. McClean, E. Prosser, E. Meehan, D. O'Malley, N. Clarke, Z. Ramtoola, and D. Brayden Binding and uptake of biodegradable poly-lactide micro- and nanoparticles in intestinal epithelia Eur. J. Pharm. Sci. 6 1998 153 163
10. R.K. Jain Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function J. Control. Release 74 2001 7 25
11. R. Gref, M. Lück, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Müller Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloid Surf. B 18 2000 301 313
12. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic(R) block copolymers as novel polymer therapeutics for drug and gene delivery J. Control. Release 82 2002 189 212
13. A. Lavasanifar, J. Samuel, and G.S. Kwon Poly(ethylene oxide)-block-poly(-amino acid) micelles for drug delivery Adv. Drug Deliv. Rev. 54 2002 169 190
14. R.T. Liggins, and H.M. Burt Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations Adv. Drug Deliv. Rev. 54 2002 191 202
15. R. Nagarajan, M. Barry, and E. Ruckenstein Unusual selectivity in solubilization by block copolymer micelles Langmuir 2 1986 210 215
16. C. Allen, D. Maysinger, and A. Eisenberg Nano-engineering block copolymer aggregates for drug delivery Colloid Surf. B 16 1999 3 27
17. J.B. Liu, Y.H. Xiao, and C. Allen Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine J. Pharm. Sci. 93 2004 132 143
18. T. Trimaille, R. Gurny, and M. Möller Synthesis and ring-opening polymerization of new monoalkyl-substituted lactides J. Polym. Sci. Part A: Polym. Chem. 42 2004 4379 4391
19. T. Trimaille, R. Gurny, and M. Möller Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems J. Biomed. Mater. Res. A 80A 2007 55 65
20. T. Trimaille, K. Mondon, R. Gurny, and M. Möller Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides) Int. J. Pharm. 319 2006 147 154
21. K. Mondon, R. Gurny, and M. Möller Colloidal drug delivery systems recent advances with polymeric micelles Chimia 62 2008 832 840
22. A. Schumacher, and A. Nordheim Progress towards a molecular understanding of Cyclosporin A-mediated immunosuppression Clin. Invest. 70 1992 773 779
23. A. Czogalla Oral cyclosporine A - the current picture of its liposomal and other delivery systems Mol. Biol. Lett. 14 2008 139 152
24. P. Pietzonka, B. Rothen-Rutishauser, P. Langguth, H. Wunderli-Allenspach, E. Walter, and H.P. Merkle Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to Caco-2 monolayers mimics particle uptake Pharm. Res. 19 2002 595 601
25. M. Gaumet, A. Vargas, R. Gurny, and F. Delie Nanoparticles for drug delivery: the need for precision in reporting particle size parameters Eur. J. Pharm. Biopharm. 69 2008 1 9
26. G.S. Rose, L.M. Tocco, G.A. Granger, P.J. DiSaia, C.T. Hamilton, A.D. Santin, and J.C. Hiserodt Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat Am. J. Obstet. Gynecol. 175 1996 593 599
27. N. Lange, J.P. Ballini, G. Wagnieres, and H. van den Bergh A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV Invest. Ophthalmol. Vis. Sci. 42 2001 38 46
28. A. Vargas, B. Pegaz, E. Debefve, Y. Konan-Kouakou, N. Lange, J.P. Ballini, H. van den Bergh, R. Gurny, and F. Delie Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos Int. J. Pharm. 286 2004 131 145
29. F. Mottu, M.J. Stelling, D.A. Rüfenacht, and E. Doelker Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection PDA J. Pharm. Sci. Technol. 55 2001 16 23
30. V.P. Torchilin Structure and design of polymeric surfactant-based drug delivery systems J. Control. Release 73 2001 137 172
31. H.M. Aliabadi, D.R. Brocks, and A. Lavasanifar Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution Biomaterials 26 2005 7251 7259
32. H.M. Aliabadi, A. Mahmud, A.D. Sharifabadi, and A. Lavasanifar Micelles of methoxy poly(ethylene oxide)-b-poly([var epsilon]-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A J. Control. Release 104 2005 301 311
33. N.J. Jain, V.K. Aswal, P.S. Goyal, and P. Bahadur Salt induced micellization and micelle structures of' PEO/PPO/PEO block copolymers in aqueous solution Colloid Surf. A 173 2000 85 94
34. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
35. B. Nottelet, C. Di Tommaso, K. Mondon, R. Gurny, and M. Möller Fully biodegradable polymeric micelles based on hydrophobic- and hydrophilic- functionalized poly(lactide) block copolymers J. Polym. Sci. Part A: Polym. Chem. 48 2010 3244 3254
36. A. Vargas, M. Zeisser-Laboube, N. Lange, R. Gurny, and F. Delie The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems Adv. Drug Deliv. Rev. 59 2007 1162 1176
37. H.M. Burt, X.C. Zhang, P. Toleikis, L. Embree, and W.L. Hunter Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel Colloids Surf. B - Biointerfaces 16 1999 161 171
38. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, S.W. Kim, and M.H. Seo In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy J. Control. Release 72 2001 191 202